Labtec opens facility for patches and oral films

Plant is certified as GMP-compliant and has room for expansion

Labtec of Germany, the pharmaceutical business of self-adhesive products manufacturer tesa, has opened a facility for the manufacture of transdermal drug delivery systems (TDS) and oral dispersible films (ODF) using its proprietary RapidFilm technology.

The unit took 18 months to complete and is located within tesa’s largest manufacturing site, tesa Werk Hamburg.

Labtec says the facility provides industrial mass production and features state-of-the-art coating and drying lines with variable coating widths, as well as modern slitting machinery and high-precision, flexible converting and packaging equipment dedicated to TDS and ODF products.

According to Labtec, the plant operates a cleanroom environment and is fully GMP compliant. There is sufficient space at the facility for future expansion.

‘It took only one-and-a-half years from the initial planning phase until completion of construction and start of operation of the unit,’ said Ingo Lehrke, Labtec’s managing director.

‘This quick implementation is the result of an extremely close and dedicated cooperation between experts from tesa, Beiersdorf and Labtec. We are now able to combine Labtec’s pharmaceutical know-how with tesa’s extensive manufacturing expertise to supply our customers with innovative drug delivery products.’

Companies